Terminal complement inhibition and control of hemolysis in patients with paroxysmal nocturnal hemoglobinuria who switched from high-dose eculizumab to ravulizumab: a phase IV, sing... by Morag Griffin, Shreyans Gandhi, Richard J. Kelly, Talha Munir, Roochi Trikha, Eden Hicks, Deepak Jain, Masayo Ogawa, Ji Yu, Petra Muus, Austin G. Kulasekararaj

Get full text